Mucopolysaccharidosis type I

GPTKB entity

Properties (67)
Predicate Object
gptkbp:instanceOf Mucopolysaccharidosis
gptkbp:causedBy deficiency of alpha-L-iduronidase
gptkbp:clinicalTrials vision problems
hearing loss
joint pain
intellectual disability
reduced range of motion
sleep apnea
respiratory issues
carpal tunnel syndrome
enlarged liver
enlarged spleen
umbilical hernia
recurrent infections
short stature
scoliosis
dental issues
gait abnormalities
joint stiffness
abnormal bone density
thickened skin
kyphosis
skin thickening
facial asymmetry
abnormal blood pressure
abnormal calcium levels
abnormal cholesterol levels
abnormal enzyme levels
abnormal facial features
abnormal glucose levels
abnormal heart size
abnormal hormone levels
abnormal kidney function
abnormal liver function
abnormal lung function
abnormal magnesium levels
abnormal phosphate levels
abnormal protein levels
abnormal uric acid levels
abnormal vitamin levels
enlarged head
large hands and feet
protruding abdomen
thickened cornea
thickened lips
gptkbp:demographics 1 in 100,000 births
gptkbp:diseaseResistance genetic testing
urine test for glycosaminoglycans
gptkbp:firstDescribedBy 1960s
gptkbp:geneticDiversity IDUA
https://www.w3.org/2000/01/rdf-schema#label Mucopolysaccharidosis type I
gptkbp:impact enzyme replacement therapy
hematopoietic stem cell transplantation
gptkbp:inheritsFrom infancy
gptkbp:legalEvent reduced life expectancy
gptkbp:nobleFamily autosomal recessive
gptkbp:relatedPatent gptkb:Mucopolysaccharidosis_type_II
gptkb:Mucopolysaccharidosis_type_IV
gptkb:Mucopolysaccharidosis_type_III
Mucopolysaccharidosis type VI
gptkbp:symptoms skeletal abnormalities
coarse facial features
developmental delay
heart valve abnormalities
hepatosplenomegaly
gptkbp:threats variable severity
gptkbp:type lysosomal storage disease